No such message found

Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: IP tells me something

IP tells me something

posted on Jun 18, 2008 04:00AM

It tells me that a merger with TPL is just around the corner. Why else get involved in something that is not going to provide the reliable revenue stream that was talked about?

As soon as Swartz is done and at least a first USPTO validation is out of the way, I think it's a done deal. They probably explored the other alternatives and decided that the merger with TPL is the better route. You can only do so much with the limited $ that they have. I don't view such a merger as necessarily a bad thing, if structured fairly.

Initially, I was surprised that the Nupower deal didn't involve TPL right from the start as a JV? Perhaps not worth going through the structuring of a JV in light of the planned merger. Would that be a second clue? All IMHO Opty

1
Jun 18, 2008 04:59AM
Share
New Message
Please login to post a reply